<DOC>
	<DOCNO>NCT01828281</DOCNO>
	<brief_summary>We hypothesize patient untreated OSAS visceral fat , fatty liver increase carotid artery thickness whereas treatment CPAP may reduce mesenteric liver fat , plasma lipid , carotid artery thickness .</brief_summary>
	<brief_title>Effects CPAP Visceral Fat Thickness</brief_title>
	<detailed_description>This propose randomize control trial ( RCT ) compare effect therapeutic CPAP versus subtherapeutic CPAP patient newly diagnose OSA reference visceral fat especially mesenteric fat thickness , liver fat , carotid artery intima medium thickness ( IMT ) , lateral pharyngeal wall ( LPW ) thickness , plasma lipid adipokines treatment period 3 month . The result study advance understanding relative role OSA obesity pathogenesis metabolic syndrome ( MetS ) whether CPAP therapy improve metabolic dysregulation .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>symptomatic patient OSA apnea hypopnea index ( AHI ) &gt; = 5/hr Recent past history myocardial infarction/stroke/heart failure , unstable angina , underlie malignancy , patient clinical feature active infection require urgent CPAP treatment associate respiratory failure prevent job loss excessive daytime sleepiness ( eg professional driver , handle dangerous machinery ) moderate severe valvular heart disease , cardiomyopathy , previous diagnosis OSA and/or previous use CPAP therapy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>